Inventor

Igor B. Roninson

Inventor

Wilmette, IL, US

Overview

1987–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 47 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes16%

C07KPeptides14%

G01NInvestigating or analysing materials by determining their chemical or physical properties14%

C12NMicroorganisms or enzymes12%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms11%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%

C12YEnzymes8%

Y10TTechnical subjects covered by former us classification3%

C07DHeterocyclic compounds3%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%

PatentTitleYear

11,014,906Quinoline-based compounds and methods of inhibiting CDK8/192021 10,993,945CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer2021 10,584,369Cell-based methods for measuring activity of a protein inhibitor2020 9,636,342'Method for treating prostate cancer'2017 9,409,873'CDKI pathway inhibitors and uses thereof'2016 9,321,737'CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer'2016 8,598,344'CDKI pathway inhibitors and uses thereof'2013 8,592,147'High-content screening for drugs against cancer and age-related diseases'2013 7,598,340'Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses'2009 7,309,584'Mutations of the MDR1 P-glycoprotein that improves its ability to confer resistance to chemotherapeutic drugs'2007 7,235,403'Reagents and methods for identifying gene targets for treating cancer'2007 6,982,313'Genes and genetic elements associated with sensitivity to chemotherapeutic drugs'2006 6,767,705'Reagents and methods for identifying and modulating expression of genes regulated by retinoids'2004 6,706,491'Reagents and methods for identifying and modulating expression of genes regulated by p21'2004 6,630,327'Methods and reagents for preparing and using immunological agents specific for P-glycoprotein'2003 6,541,603'Genes and genetic elements associated with sensitivity to platinum-based drugs'2003 6,537,754'Association of kinesin with sensitivity to chemotherapeutic drugs'2003 6,479,639'Monoclonal antibody to a human MDR1 multidrug resistance gene product and uses'2002 6,376,241'Methods and applications for efficient genetic suppressor elements'2002 6,326,488'Gene and genetic elements associated with sensitivity to chemotherapeutic drugs'2001 6,281,011'Methods and applications for efficient genetic suppressor elements'2001 6,268,134'Method and applications for efficient genetic suppressor elements'2001 6,238,867'Compositions, methods and kits for identifying naturally occurring RNA sequences having affinity for RNA-binding proteins'2001 6,197,521'Genes and genetic elements associated with control of neoplastic transformation in mammalian cells'2001 6,171,786'Methods for preventing multidrug resistance in cancer cells'2001 6,083,745'Genes and genetic elements associated with control of neoplastic transformation in mammalian cells'2000 6,083,746'Genes and genetic elements associated with control of neoplastic transformation in mammalian cells'2000 6,060,244'Genes and genetic elements associated with sensitivity to chemotherapeutic drugs'2000 6,043,340'Association of kinesin with sensitivity to chemotherapeutic drugs'2000 6,030,796'Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses'2000 5,994,088'Methods and reagents for preparing and using immunological agents specific for P-glycoprotein'1999 5,972,598'Methods for preventing multidrug resistance in cancer cells'1999 5,942,389'Genes and genetic elements associated with sensitivity to cisplatin'1999 5,891,654'Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression'1999 5,866,327'Association of kinensin with sensitivity to chemotherapeutic drugs'1999 5,811,234'Methods and applications for efficient genetic suppressor elements'1998 5,789,389'BCL2 derived genetic elements associated with sensitivity to chemotherapeutic drugs'1998 5,773,280'Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses'1998 5,753,432'Genes and genetic elements associated with control of neoplastic transformation in mammalian cells'1998 5,728,519'Assay for virulent revertants of attenuated live vaccines and kits therefor'1998 5,665,550'Genes and genetic elements associated with sensitivity to chemotherapeutic drugs'1997 5,550,018'Test for virulent genomic nucleotide 472 revertants in attenuated live poliovirus type 3 vaccines'1996 5,464,753'Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression'1995 5,434,075'Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses'1995 5,217,889'Methods and applications for efficient genetic suppressor elements'1993 5,206,352'Compositions for clones containing DNA sequences associated with multidrug resistance in human cells'1993 4,675,283'Detection and isolation of homologous, repeated and amplified nucleic acid sequences'1987

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1987–1999Based in Chicago, IL, US· patent location history

1993–2009Patents assigned to UNIV ILLINOIS (33)· patent assignee history

1993–2013Patents assigned to RONINSON IGOR B (3)· patent assignee history

1995–2009Based in Wilmette, IL, US· patent location history

2007Based in Cohoes, NY, US· patent location history

2013Patents assigned to Senex Biotechnology (2)· patent assignee history

2013–2021Based in Lexington, SC, US· patent location history

2013Based in Loudonville, NY, US· patent location history

2016–2021Patents assigned to SENEX BIOTECHNOLOGY INC (5)· patent assignee history

2017–2021Patents assigned to UNIV SOUTH CAROLINA (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV ILLINOIS	33	1993–2009
SENEX BIOTECHNOLOGY INC	5	2016–2021
RONINSON IGOR Bself	3	1993–2013
Senex Biotechnology	2	2013
UNIV SOUTH CAROLINA	2	2017–2021

Locations

Location	Patents	Span
Wilmette, Illinois, US	31	1995–2009
Lexington, SC, US	7	2013–2021
Chicago, Illinois, US	7	1987–1999
Loudonville, New York, US	1	2013
Cohoes, New York, US	1	2007